Global IVF Devices Market to Grow at 10% CAGR Due to the High Success Rate of the IVF Procedure: Technavio

Technavio has published a new report on the global IVF devices market from 2017-2021. (Graphic: Business Wire)

LONDON--()--According to the latest market study released by Technavio, the global in-vitro fertilization (IVF) devices market is projected to grow to USD 2.96 billion by 2021, at a CAGR of more than 10% over the forecast period.

This research report titled ‘Global IVF Devices Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes an up to date analysis and forecasts for various market segments and all geographical regions.

In-vitro fertilization is the process in which a woman’s egg is fertilized externally in a laboratory, and the fertilized egg is returned to the woman’s uterus. The high success rate of the in-vitro fertilization procedure is driving more women to opt for this procedure, leading to the growth of the market,” says Srinivas Sashidhar, a lead analyst at Technavio for men’s health, women’s health, and genitourinary research.

Request a sample report: http://www.technavio.com/request-a-sample?report=56280

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Based on end-users, the report categorizes the global IVF devices market into the following segments:

  • Fertility clinics
  • Hospitals
  • Research clinics

Fertility clinics

Fertility clinics comprise the largest end-user segment of the IVF devices market, generating over 60% of the overall revenue. The high revenue generation in IVF clinics is driven by the high patient inflow for IVF treatments in these places. Semen collection for males and ultrasound and sonography for females are the standard diagnostic tests performed at the center to examine fertility issues. With the current advancements in technology, there are various treatment options provided. The high success rate and comparative simplicity of the IVF procedure are driving more patients to opt for the treatment option.

Hospitals

Hospitals with fertility medical facilities are important revenue contributors to the global IVF devices market. Large multispecialty hospitals and hospital groups that work under government sponsorship or through private entities are the secondary end-users, which highly influence market growth,” says Srinivas.

Large hospitals procure consumables in bulk and engage with many suppliers, reimbursement authorities, and government organizations. They provide diagnosis and monitoring facilities to conduct infertility diagnostic procedures, thus driving the sales of IVF devices products.

Research clinics

Research centers are focused on developing innovative IVF and related diagnostic solutions and products. They support research personnel and clinicians to procure and analyze data related to patient diagnosis, prognosis, and treatment monitoring for infertility. Also, these institutes focus on identifying unfulfilled niches and limitations to ensure the successful implementation of IVF devices being used in the culture of embryos. The great number of universities and academic centers performing infertility experiments and studies to evaluate the performance of IVF devices is driving the growth of the market segment.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • Cook Medical
  • CooperSurgical
  • Thermo Fisher Scientific
  • Vitrolife

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cardiovascular and metabolic disorders, in-vitro diagnostics, and patient monitoring devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

According to the latest market study released by Technavio, the global in-vitro fertilization (IVF) devices market is projected to grow to USD 2.96 billion by 2021, at a CAGR of more than 10%.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com